8. Amenta AR, Yilmaz A, Bogdanovich S, McKechnie BA, Abedi M, et al. (2011) Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci U S A 108: 762–7. 9. Krag TO, Bogdanovich S, Jensen CJ, Fischer MD, Hansen-Schwartz J, et al. (2004) Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc Natl Acad Sci U S A 101: 13856–60. 10. Peter AK, Marshall JL, Crosbie RH (2008) Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex. J Cell Biol 183: 419–27. 11. Mattei E, Corbi N, Di Certo MG, Strimpakos G, Severini C, et al. (2007) Utrophin up-regulation by an artificial transcription factor in transgenic mice. PLoS ONE 2: e774. 12. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, et al. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4: 1441–4. 13. Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, et al. (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol 162: 486–98. 14. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, et al. (2003) Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther 304: 453–63. SMT C1100 Reduces mdx Dystrophic Symptoms 15. Burdi R, Rolland JF, Fraysse B, Litvinova K, Cozzoli A, et al. (2009) Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests. J Appl Physiol 106: 1311–24. 16. Cooper ST, Lo HP, North KN (2003) Single section Western blot: improving the molecular diagnosis of the muscular dystrophies. Neurology 61: 93–7. 17. Squire S, Raymackers JM, Vandebrouck C, Potter A, Tinsley J, et al. (2002) Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum Mol Genet 11: 3333–44. 18. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–8. 19. Hirst RC, McCullagh KJ, Davies KE (2005) Utrophin upregulation in Duchenne muscular dystrophy. Acta Myol 24: 209–16. 20. Miura P, Jasmin BJ (2006) Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Trends Mol Med 12: 122–9. 21. De Luca A, Nico B, Rolland JF, Cozzoli A, Burdi R, et al. (2008) Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. Neurobiol Dis 32: 243–53. PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e19189